Time to Complete. North Coast will complete the Services and provide the Deliverables to Omeros as described in Section 2.3(a) within no longer than [†].
Time to Complete. A final Compliance Inspection Report from the approved Appraiser stating all Work has been satisfactorily completed, Contractor’s Lien Release and the Borrower’s Letter of Completion must be received by the Lender within two weeks of completion or six (6) months of the date of the note, whichever is earlier. If, for whatever reason, the final inspection verifying that all Work is completed is not received within six (6) months of the date of the note, the Lender has the right to make a principal reduction payment with the funds being held in escrow. If the funds held in escrow are used to make a principal reduction, the final payment to the Contractor will not be available from the Lender unless the Lender has agreed in writing through an approved Change Order to extend such time.
Time to Complete. The Contractor shall complete all directed work as set out in Section 1.0 of this Contract. A completion date will be determined once the extent of damage has been determined and a time frame will be put in place to be followed.
Time to Complete. Lessee shall commence the repairs or rebuilding as soon as reasonably practicable after insurance proceeds are received and complete same with due diligence as soon as reasonably practicable, subject to extensions for Force Majeure, but in no event longer than one (1) year. If Lessor or the Brazos River Authority, in either’s sole discretion, determines the damaged Improvements create a hazard to health, safety or welfare, Lessor or Brazos River Authority may establish a shorter time frame for repair, replacement or removal.
Time to Complete. [†] Omeros shall have no liability under this Section 1.2, provided that until Omeros has performed the matters described in this Section 1.2, North Coast will be excused from providing any Services or Deliverables that are directly dependent upon such performance unless Omeros’ delay is caused by North Coast’s failure to timely provide any of the Services and Deliverables called for in this Additional Target Research Plan. [†]
(a) Description. [†].
Time to Complete. [†]. Omeros shall have no liability under this Section 2.2, provided that until Omeros has performed the matters described in this Section 2.2, North Coast will be excused from providing any Services or Deliverables that are directly dependent upon such performance and any deadlines for such Services and Deliverables shall be extended by the † DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION number of additional days in excess of [†]; provided, however, that North Coast will not be excused from providing any Services or Deliverables and no deadlines for any Services or Deliverables shall be extended if Omeros’ delay is caused by North Coast’s failure to timely provide any of the Services and Deliverables called for in this Additional Target Research Plan. [†].
Time to Complete. Time of completion for this project shall be one hundred thirty-five (135) calendar days from the issuance date of the District’s Notice to Proceed.
Time to Complete. North Coast will complete the Services and provide the Deliverables with respect to an Optional Candidate as described in Section 2.3 within [†].
Time to Complete. North Coast will complete the Services and provide the Deliverables with respect to an Optional Candidate as described in Section 2.3 within [†]. † DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION This Initial Research Plan is accepted and acknowledged by each Party through the signature of its authorized representative below, and is effective as of the date first set forth above in this Initial Research Plan. NORTH COAST BIOLOGICS LLC OMEROS CORPORATION By: /s/ Xxxxxx Xxxxx Name: Xxxxxx Xxxxx By: Name: /s/ Xxxxxxx X. Xxxxxxxxx Xxxxxxx X. Xxxxxxxxx, M.D. Title: President Title: Chairman & CEO † DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION This Research Plan for Antibodies to [ADDITIONAL TARGET] is dated as of [XXXX] and is between Omeros Corporation (“Omeros”) and North Coast Biologics LLC (“North Coast”) and constitutes an “Additional Target Research Plan” under the Agreement for Antibody Development dated October 31, 2008 between Omeros and North Coast (the “Development Agreement”). Capitalized terms used but not defined in this Additional Target Research Plan shall have the meanings given to them in the Development Agreement.
Xxxx 0 — [†]
(a) Description. [†].
Time to Complete. Omeros intends to complete the testing described in Section 2.4(a) within [†].
